Introduction
The University of Akron’s policy of collecting DNA samples from prospective hires has sparked a contentious debate over the moral ramifications of this practice. This policy, which required applicants to provide genetic information as a condition of employment, raised serious concerns about the potential abuse of sensitive personal information. This policy’s effects extend well beyond the University of Akron, addressing the appropriate application of biotechnology. A fine line must be drawn between an organization’s alleged right to carry out extensive background checks and a person’s inalienable right to decide how their genetic information is used.
Case Review
Gabrieli’s Model
The Three-Zone Confidentiality Model by Gabrieli is a potential framework for examining the current case. The model consists of three zones: the innermost zone, which contains the most sensitive data and should always be protected, is at the center of the model (Dick et al., 1997). Genetic information likely belongs in this innermost zone, as it includes information on a person’s susceptibility to particular illnesses.
Genetic information is a very sensitive part of a person’s identity, and there is a substantial risk that it will be misused in discriminatory ways. Even though the institution argues that the policy was intended only for background checks, the mere availability of DNA samples creates the possibility that this private information may be exploited (Shapiro, 2009). Without the participants’ awareness, the university’s strategy of obtaining DNA samples for background checks effectively gives them access to this most private realm of personal data.
Patients—or, in this case, employees—need the freedom to choose which details of their personal information are kept completely private. The University of Akron essentially violates this concept by requiring the collection of DNA samples. The model requires data integrity for all stakeholders in the healthcare system (Dick et al., 1997). Employees should have the same level of protection from the illegal use of their genetic data as patients do from unauthorized access to medical records. Gabrieli’s Three-Zone Confidentiality Model suggests that the University of Akron’s policy clearly violates the confidentiality principle.
Patient Control of Information
Patient control over information is a crucial tenet of genetic privacy. People should be free to choose how their genetic information is shared and whether or not to undergo genetic testing (Huang et al., 2022). The University of Akron effectively took away people’s autonomy over their personal genetic data, which can indicate predispositions to a variety of health disorders like cancer, heart disease, and mental illness.
The ramifications of this approach could be dire since companies’ access to genetic data could be abused for discriminatory ends, such as withholding promotions based on alleged health risks. Furthermore, regardless of the policy’s original intention, once an employer has access to an employee’s genetic data, there is a risk of unauthorized disclosure. This is why the temptation to misuse this information, as noted by adjunct professor Matt Williams, is a legitimate concern.
Privacy and Confidentiality Laws
Significant privacy concerns arise from the University of Akron’s policy, especially in light of the Genetic Information Nondiscrimination Act (GINA). GINA expressly forbids employers from using a person’s genetic information to decide whether to hire, fire, or promote that person (Shapiro, 2009). This rule appears to be directly violated by the university’s policy of seeking DNA samples, which could reveal sensitive genetic information regarding a person’s predisposition to specific health disorders.
A spokesperson for the institution maintained that the policy was appropriate. However, this kind of discrimination based on a person’s genetic composition might undermine GINA’s whole goal (Shapiro, 2009). Companies should not have a way to abuse sensitive genetic data, as doing so may have a momentous impact on people’s access to equitable treatment at work.
Use of Information for Social Good
The University of Akron’s strategy also raises serious questions about the ethical use of genetic data. Although genetic data can indeed help advance personalized medicine, there are serious concerns about its misuse (Hawkins, 2023). The drive for organizations to use such private information for purposes other than their intended use, including biased recruiting procedures, threatens the core value of nondiscrimination. To ensure that genetic data is collected only for purposes that prioritize societal benefit without compromising civil liberties, institutions must establish clear boundaries.
Medical Ethics
The University of Akron’s practice raises serious ethical issues in medicine. The university’s policy violates the principle of respect for autonomy, which is the freedom to make informed decisions about one’s own life (HĂĽbner et al., 2022). Workers were not given the option to decline to disclose genetic information, which might reveal extremely sensitive details about their health.
Moreover, the need to refrain from harming others is mandated by the concept of non-maleficence, which is likewise undermined (HĂĽbner et al., 2022). Employers may improperly use genetic data, which could result in discrimination; furthermore, sharing such private information may lead to social stigmatization. Notwithstanding the university’s well-intentioned efforts to provide a thorough background check, the moral ramifications of exploiting genetic data far exceed any apparent advantages.
Case Development
Matt Williams’s case and the University of Akron’s controversial DNA-testing policy for new hires became more contentious after the university withdrew its offer to rehire Williams as an adjunct instructor. Williams claims that this was done as payback for his ongoing support of adjunct faculty rights (Jaschik, 2010). Initially rehired for the 2010 academic year, Williams had earlier quit in protest over the DNA policy (Jaschik, 2010).
However, after writing letters to trustees about the treatment of contingent professors, Williams lost his post (Jaschik, 2010). Williams and the New Faculty Majority organization said it was a reprisal for his outspoken stance, especially his resistance to the DNA policy. In contrast, the university cited Williams’ prior contract violation as the reason (Jaschik, 2010). Regardless, the University of Akron’s policy did not seem to be pursued by other educational institutions; to this day, there is no established practice of DNA testing before recruitment.
Conclusion
The story of the University of Akron’s DNA testing policy for prospective hires is instructive, as it shows the value of preserving legal safeguards for genetic privacy. Institutions may gather this sensitive data with the best of intentions, but there is always a risk that it will be used unfairly. The cancellation of Matt Williams’ raise raises more questions about the university’s handling of this matter and the purported rehire offer, reportedly done as punishment for his opposition to the policy. In the future, solid ethical frameworks that balance the preservation of individual rights with scientific advancement must be put in place to govern the use of genetic data. Nonetheless, human autonomy and ethical stewardship of biotechnology need not conflict.
References
Barner, C. (2021). Social media and communication. Sage.
Brownlie, D. (2021). Andragogy. West.net.
Cummings, J. N., Butler, B., & Kraut, R. (2021). The quality of online social relationships. Communications of the ACM, 46(7), 103-108.
Shapiro, J. (2009). When your boss wants your DNA. NPR.
Jaschik, S. (2010). No job for adjunct who took a stand. Inside Higher Ed | Higher Education News, Events and Jobs.
Dick, R. S., Steen, E. B., & Detmer, D. E. (1997). Computer-based patient record technologies. National Academies Press.
Huang, S. J., Amendola, L. M., & Sternen, D. L. (2022). Variation among DNA banking consent forms: Points for clinicians to bank on. Journal of Community Genetics, 13(4), 389–397.
Hawkins, A. (2023). Academic paper based on Uyghur genetic data retracted over ethical concerns. The Guardian.
HĂĽbner, U. H., Egbert, N., & Schulte, G. (2022). Ethical issues: Patients, providers, and systems. In U. H. HĂĽbner, G. M. Wilson, T. S. Morawski, & M. J. Ball (Eds.), Nursing informatics: A health informatics, interprofessional and global perspective (pp. 465-483). Springer International Publishing.
